A detailed history of Kathleen S. Wright Associates Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Kathleen S. Wright Associates Inc. holds 12,000 shares of PFE stock, worth $314,880. This represents 0.14% of its overall portfolio holdings.

Number of Shares
12,000
Previous 12,000 -0.0%
Holding current value
$314,880
Previous $335,000 3.58%
% of portfolio
0.14%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$25.89 - $29.73 $51,780 - $59,460
2,000 Added 20.0%
12,000 $333,000
Q3 2023

Oct 20, 2023

BUY
$32.09 - $37.51 $320,900 - $375,100
10,000 New
10,000 $331,000
Q4 2021

Feb 02, 2022

BUY
$41.32 - $61.25 $413,200 - $612,500
10,000 New
10,000 $591,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kathleen S. Wright Associates Inc. Portfolio

Follow Kathleen S. Wright Associates Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kathleen S. Wright Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kathleen S. Wright Associates Inc. with notifications on news.